Frontiers in Oncology · 2018 · 21 citations · 20 references
MedicineOncologyRadiation OncologyBreast OncologyBreast Radiation OncologyTreatment PlanningBreast Cancer OncologyBreast Cancer RadiotherapyBreast Radiation CareBreast-conserving TherapyDeep Inspiration Breath HoldRadiation TherapyBreast Cancer Radiotherapy Cardiac ToxicityBreath-hold RadiotherapyCardiac Dose ReductionChi-square TestHistogramsLeft-sided Breast Cancer Radiation PlanningLeft-sided Breast RadiotherapyPost-mastectomy Radiotherapy
The purpose of this study was to evaluate patient-related non-dosimetric predictors of cardiac sparing with the use of deep inspiration breath-hold (DIBH) in patients with left-sided breast cancer undergoing irradiation (RT). Material and Methods We retrospectively reviewed charts and treatment plans of one-hundred and three patients with left-sided breast cancer. All patients had both free-breathing (FB) and DIBH (with body surface tracking) plans available. Mean heart dose (MHD) and V4 (heart volume receiving at least 4 Gy) were extracted from dose volume histograms. Fisher’s exact and Chi-square tests were used to identify predictors of reductions in MHD and V4 after DIBH. Results One-hundred and three patients were identified and most underwent mastectomy. MHD and V4 decreased significantly in DIBH plans (0.74 ± 0.25 Gy vs. 1.72 ± 0.98 Gy, p < 0.0001 for MHD; 4 ± 4.98 cc vs. 20.79 ± 18.2 cc, p < 0.0001 for V4). Body mass index (BMI), smoking and timing of CT simulation (spring/winter vs. summer/fall) were significant predictors of reduction in MHD whereas BMI, field size, chemotherapy, axillary dissection, and timing of CT simulation predicted reduction in V4. On multivariate analysis, BMI and timing of CT simulation remained significant predictors of the heart-sparing effect of DIBH. Conclusions In the setting of limited resources, identifying patients who will benefit the most from DIBH is extremely important. Prior studies have identified multiple dosimetric predictors of cardiac sparing and hereby we identified new non-dosimetric factors such as BMI and timing of treatments.
20
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Sarah C. Darby, Marianne Ewertz, Paul McGale et al. · New England Journal of Medicine · 2013 · 4K citations · Full text
Medicine, Cardiology, Oncology +17
Sarah C. Darby, Paul McGale, Carolyn Taylor et al. · The Lancet Oncology · 2005 · 1K citations
Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer
Greger Nilsson, Lars Holmberg, Hans Garmo et al. · Journal of Clinical Oncology · 2011 · 386 citations · Full text
Inger Højris, Marie Overgaard, Jens Overgaard · The Lancet · 1999 · 352 citations
Medicine, Cardiology, Oncology +17